'Asthma exacerbations' presentation slideshows

Severe Acute Asthma in the Emergency Department: CTS Symposium.

Severe Acute Asthma in the Emergency Department: CTS Symposium. Brian H. Rowe, MD, MSc, CCFP(EM) Canada Research Chair in Emergency Airway Diseases Associate Dean (Clinical Reseaerch), FoMD Professor, Department of Emergency Medicine University of Alberta. Conflicts.

848 views • 59 slides

Asthma

Asthma. A Chronic disease of the airways that may cause: Wheezing Breathlessness Chest tightness Nighttime or early morning coughing. The bronchospasm characteristic of the acute asthmatic attack is typically reversible. (???????????? ?? ?? ????? ????? ???? ????????? ???? ??? ??? ???)

689 views • 56 slides

G IN A

G IN A. lobal itiative for sthma. GINA Workshop Report. Topics: Definition Burden of Asthma Risk Factors Mechanisms Diagnosis and Classification Education and Delivery of Care Six Part Asthma Management Plan Research Recommendations. Definition of Asthma.

544 views • 54 slides

Faculty

Faculty. Michael E. Wechsler, MD Professor of Medicine Director, NJH Cohen Family Asthma Institute Department of Medicine National Jewish Health Denver, Colorado. Jonathan Corren, MD Clinical Associate Professor of Medicine and Pediatrics Divisions of Clinical Immunology and Allergy

535 views • 53 slides

Tips for Caring for Patients with Reactive Airways

Tips for Caring for Patients with Reactive Airways. Jason E. Knuffman, MD Allergy October 27, 2004. Objectives for CME. Review the goals of asthma care Review the fundamental therapeutic options for asthmatics

545 views • 41 slides

Revised 2006

Revised 2006. Goals of Therapy. Therapy for chronic asthma is directed at suppressing the underlying inflammatory response and normalizing pulmonary function. The goals of treatment for chronic asthma are to: Reduce impairment prevent chronic, troublesome symptoms

401 views • 40 slides

??? ???? ?????? ??????

??? ???? ?????? ??????. ??? ???? ?????? ??????. BRONCHIAL ASTHMA. BY Mohamed Magdy Zedan Resident of Pediatric,Mansoura University Children Hospital. Definition :. It is a diffuse obstructive lung disease ,with 3 characteristics: High degree of reversibility

973 views • 37 slides

Inner-City Asthma and Anti-IgE

Inner-City Asthma and Anti-IgE. William W. Busse, M.D. University of Wisconsin School of Medicine and Public Health Madison, WI, USA. Disclosure Slide. Employment University of Wisconsin Financial Interests Advisory Boards: Merck

489 views • 26 slides

Magnesium Sulfate and Asthma in the Pediatric Population

Magnesium Sulfate and Asthma in the Pediatric Population. Lauren Cantor Advanced Medical Therapeutics March 2, 2007. Outline:. Background Information Asthma Definition, Epidemiology Magnesium Sulfate Mechanism of action in asthma, History Does It Work and What does the literature say??

627 views • 24 slides

Classification of Chronic Asthma Severity on Treatment

PCCP Council on Asthma. Classification of Chronic Asthma Severity on Treatment. *Objective measures take precedence over subjective complaints. The higher severity level of any domain will be the basis of the final severity level.

2.15k views • 22 slides

CHAT Asthma Collaborative

Safety and Quality Collaborative. CHAT Asthma Collaborative. CHAT Safety and Quality Collaborative. Objectives: To describe fundamental tenets of quality improvement To demonstrate ways to demonstrate quality improvement data

239 views • 14 slides

CHAT Asthma Collaborative

Safety and Quality Collaborative. CHAT Asthma Collaborative. CHAT Safety and Quality Collaborative. Objectives: To describe fundamental tenets of quality improvement To demonstrate ways to demonstrate quality improvement data

232 views • 14 slides

EFFICACY AND EFFECTIVINESS OF INACTIVED INFLUENZA VIRUS VACCINE

EFFICACY AND EFFECTIVINESS OF INACTIVED INFLUENZA VIRUS VACCINE. Factors influencing vaccine efficacy. Closeness of the match between the vaccine strain and the circulating virus Age of vaccinee: older people do not respond as well

240 views • 11 slides

SAFETY OF INFLUENZA VACCINATION

SAFETY OF INFLUENZA VACCINATION. Symptom. Vaccine (%). Placebo (%). Feverish. 5.7. 4.2. Malaise. 7.2. 6.3. Myalgia. 4.8. 4.2. Headache. 6.9. 7.6. Nausea. 4.5. 2.4. Sore arm. 20.1. 4.9. Influenza vaccine post - injection symptoms in elderly subjects.

207 views • 8 slides

Reducing Exposure to House Dust Mites

590 views • 6 slides

Chest Specialist in Delhi

81 views • 3 slides